Market capitalization | HKD54.83b |
Enterprise Value | HKD46.04b |
P/E (TTM) P/E ratio | 40.45 |
EV/FCF (TTM) EV/FCF | 39.82 |
EV/Sales (TTM) EV/Sales | 1.50 |
P/S ratio (TTM) P/S ratio | 1.78 |
P/B ratio (TTM) P/B ratio | 3.24 |
Revenue growth (TTM) Revenue growth | -1.97% |
Revenue (TTM) Revenue | HKD30.73b |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
17 Analysts have issued a Alibaba Health Information Technology forecast:
17 Analysts have issued a Alibaba Health Information Technology forecast:
Sep '24 |
+/-
%
|
||
Revenue | 30,729 30,729 |
2%
2%
|
|
Gross Profit | 7,112 7,112 |
2%
2%
|
|
EBITDA | 1,316 1,316 |
299%
299%
|
EBIT (Operating Income) EBIT | 1,256 1,256 |
364%
364%
|
Net Profit | 1,308 1,308 |
44%
44%
|
In millions HKD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Alibaba Health Information Technology Ltd. is an investment holding company, which engages in the provision of Internet technology, service tools, and platforms to offer medical and healthcare services. Its activities include self-operated healthcare product sales, e-commerce platform services, tracking services, and innovative healthcare related services and others. The company was founded on March 11, 1998 and is headquartered in Hong Kong.
Head office | Bermuda |
CEO | Di Shen |
Employees | 1,435 |
Website | www.ir.alihealth.cn |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.